August 24th, 2017

Next
A full text version of this article is available.
To access article obtain online access here or login
 
Title:
Concomitant Intrauterine Morcellation of a Submucosal Fibroid Followed by Radiofrequency Impedance Controlled Endometrial Ablation for the Treatment of Menorrhagia: A Report of 2 Cases
Authors:  Man Hin Menelik Lee, M.B.B.S., MRCOG, FHKCOG, FHKAM(OG), and Tomoko Matsuzono, M.B.B.S., MRCOG, FHKCOG, FHKAM(OG)
 
BACKGROUND: Menorrhagia is a common disorder worldwide, with submucosal fibroids significantly being linked to heavy menstrual blood loss. Hysteroscopic resection of the submucosal fibroid may be sufficient for the control of heavy menstruation, and concomitant endometrial ablation may further improve symptoms. The 2 case studies presented here demonstrated 2 of the first cases of the concomitant use of hysteroscopic morcellation of submucosal fibroid via MyoSure tissue remover device followed by second generation radiofrequency impedance controlled endometrial ablation in the form of the NovaSure system.
CASES: Two women in their 40s presented with menorrhagia secondary to a submucosal fibroid. Concomitant hysteroscopic morcellation with MyoSure and NovaSure endometrial ablation successfully managed both of their symptoms without complications.

CONCLUSION: The cases showed the safety, efficiency, and effectiveness of the concomitant use of hysteroscopic morcellation of submucosal fibroids via MyoSure tissue remover device followed by second generation radiofrequency impedance controlled endometrial ablation in the form of the NovaSure system.
Keywords:  endometrial ablation; fibroid; fibroid tumor; fibroid uterus; fibroids, uterine; fibroma, uterine; fibromyoma; gynecologic surgery; hypermenorrhea; hysteroscopy; hysteroscopic surgery; hysteroscopic surgical procedures; leiomyoma; leiomyoma, uterine; menorrhagia; menstruation; uterine endoscopy
   
   
  Acrobat Reader 7.0 is recommended to properly view and print the article.
Reader can be downloaded from